Martin Nicholas to Glioma
This is a "connection" page, showing publications Martin Nicholas has written about Glioma.
Connection Strength
1.310
-
Update in the treatment of high-grade Gliomas. Neurol Clin. 2013 Aug; 31(3):847-67.
Score: 0.376
-
Emerging therapies for malignant glioma. Expert Rev Anticancer Ther. 2007 Dec; 7(12 Suppl):S29-36.
Score: 0.260
-
Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas. Clin Cancer Res. 2006 Dec 15; 12(24):7261-70.
Score: 0.243
-
Chemotherapy for malignant glioma. Expert Rev Neurother. 2005 Nov; 5(6 Suppl):S41-9.
Score: 0.225
-
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas. J Neurooncol. 2021 Dec; 155(3):297-306.
Score: 0.170
-
Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies. Clin Cancer Res. 1999 Jun; 5(6):1325-30.
Score: 0.036